Cassava says two senior employees included in federal probes

Following years of accusations of scientific malfeasance, Alzheimer’s drug developer Cassava Sciences disclosed Monday that two of its senior employees are being investigated by the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Labcorp inks $237.5M buyout of Opko’s reproductive, women’s health testing assets

Dive Brief: Labcorp struck a deal Thursday to acquire clinical diagnostics, reproductive and women’s health testing assets from Bioreference Health, a subsidiary of Opko Health,

March 29, 2024

Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-loss | Psychedelic Invest

Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on

July 16, 2024

Viromed Medical AG will not acquire ActivCell Group AG and is focusing on another strategic option with greater added value – Biotech Investments

Viromed Medical AG / Key word(s): Mergers & Acquisitions Viromed Medical AG will not acquire ActivCell Group AG and is focusing on another strategic option

November 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.